Position in JNJ
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$1,033,234,532
-$44,713,601 QoQ
Shares Held
4,068,333
-7.7% QoQ
Ownership
0.169%
of shares outstanding
% of Portfolio
1.22%
of 13F equity value
Holder Rank
#65
of 4,676 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026MACKENZIE FINANCIAL CORP holds $3,273,366,479 across 12 Drug Manufacturers - General names. JNJ ranks #1 (31.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
This page
|
4,068,333 | $1,033,234,532 | |
| 2 | LLY |
ELI LILLY & Co
|
580,460 | $696,221,195 | |
| 3 | ABBV |
AbbVie Inc.
|
1,707,786 | $429,747,269 | |
| 4 | MRK |
Merck & Co., Inc.
|
2,373,431 | $304,985,883 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
2,033,130 | $256,865,644 | |
| 6 | AZN |
Astrazeneca PLC
|
1,328,471 | $251,904,671 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
2,064,284 | $118,944,044 | |
| 8 | PFE |
Pfizer Inc
|
3,938,865 | $94,847,869 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,033,234,532 | 4,068,333 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $1,077,948,133 | 4,409,868 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $920,525,810 | 4,448,059 | Shares | Sole | 2026-02-18 | |
| 2025-09-30 | $675,284,435 | 3,641,918 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $557,604,710 | 3,650,440 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $561,150,652 | 3,383,687 | Shares | Sole | 2025-05-07 | |
| 2024-12-31 | $449,132,739 | 3,105,606 | Shares | Sole | 2025-05-02 | |
| 2024-09-30 | $542,802,953 | 3,349,395 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $502,985,523 | 3,441,335 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $535,287,118 | 3,383,824 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $531,203,145 | 3,389,072 | Shares | Sole | 2024-01-30 | |
| 2023-09-30 | $545,788,495 | 3,504,260 | Shares | Sole | 2023-10-25 | |
| 2023-06-30 | $609,520,944 | 3,682,461 | Shares | Sole | 2023-08-03 | |
| 2023-03-31 | $536,209,635 | 3,459,417 | Shares | Sole | 2023-04-24 | |
| 2022-12-31 | $649,272,128 | 3,675,472 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $582,310,278 | 3,564,583 | Shares | Sole | 2022-10-07 | |
| 2022-06-30 | $648,379,948 | 3,652,639 | Shares | Sole | 2022-08-10 | |
| 2022-03-31 | $633,390,599 | 3,573,834 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $551,692,880 | 3,224,954 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $557,108,785 | 3,449,590 | Shares | Sole | 2021-11-08 | |
| 2021-06-30 | $595,039,232 | 3,611,990 | Shares | Sole | 2021-08-11 | |
| 2021-03-31 | $595,846,323 | 3,625,472 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $533,015,213 | 3,386,804 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $563,345,394 | 3,783,889 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $540,690,848 | 3,844,776 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $442,977,858 | 3,378,158 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||